BANK VONTOBEL/CALL/ROCHE GS/240/0.02/20.12.24 Share Price

Warrant

WROAMV

CH1290617823

Real-time Bid/Ask 13:06:14 27/06/2024 BST
0.4 CHF / 0.41 CHF +1.25% Intraday chart for BANK VONTOBEL/CALL/ROCHE GS/240/0.02/20.12.24
Current month+83.49%
1 month+76.99%
Date Price Change
26/06/24 0.4 -6.98%
25/06/24 0.43 -7.53%
24/06/24 0.465 +5.68%
21/06/24 0.44 +11.39%
20/06/24 0.395 0.00%

Delayed Quote Swiss Exchange

Last update June 26, 2024 at 04:20 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying ROCHE HOLDING AG
IssuerLogo Issuer Vontobel Vontobel
WROAMV
ISINCH1290617823
Date issued 26/09/2023
Strike 240 CHF
Maturity 20/12/2024 (176 Days)
Parity 50 : 1
Emission price 0.45 CHF
Emission volume N/A
Settlement Physisch
Currency CHF

Technical Indicators

Highest since issue 0.56 CHF
Lowest since issue 0.116 CHF
Spread 0.01 CHF
Spread %2.44%

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
20
Last Close Price
249.6 CHF
Average target price
278.1 CHF
Spread / Average Target
+11.40%
Consensus
  1. Stock Market
  2. Warrants
  3. WROAMV Warrant